Jefferies is out with its report today on Jarden JAH, maintaining Buy.
In a note to clients, Jefferies writes, "Although we had expected weather and timing issues to make for a muted
Q2, JAH's organic sales growth and margins were below our expectations, with below-the-line items making up for a majority of the shortfall. However, we continue to believe that the second half remains on track and look for double-digit EPS growth in the 3Q and 4Q."
Jefferies maintains a $42 PT on JAH.
At the time of posting, shares of JAH were trading at $31.53, down 4.86% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in